| RS115600896 |
TMEM63A
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, TMEM63A-related disorder |
| RS115602636 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS115604294 |
CAPN12
|
Health Risk |
Conflicting classifications of pathogenicity |
CAPN12-related disorder, CAPN12-related disorder |
| RS115605600 |
MCCC1
|
Health Risk |
Conflicting classifications of pathogenicity |
3-methylcrotonyl-CoA carboxylase 1 deficiency, 3-methylcrotonyl-CoA carboxylase 1 deficiency |
| RS115605801 |
COG7
|
Health Risk |
Conflicting classifications of pathogenicity |
COG7 congenital disorder of glycosylation, COG7-related disorder |
| RS115606722 |
TACSTD2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115607360 |
MTMR14
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115607645 |
PALLD
|
Health Risk |
Conflicting classifications of pathogenicity |
Pancreatic cancer, susceptibility to |
| RS115612705 |
KANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115614731 |
DOK7
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 10, Fetal akinesia deformation sequence 1 |
| RS115620008 |
HAL
|
Health Risk |
Conflicting classifications of pathogenicity |
Histidinemia, Histidinemia |
| RS115622575 |
RYR2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiovascular phenotype |
| RS115623365 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Nemaline myopathy 2 |
| RS1156240396 |
INF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 5, Charcot-Marie-Tooth disease dominant intermediate E |
| RS115624085 |
BCHE
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS1156243243 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1156245096 |
HADHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency 1 |
| RS1156250216 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1156283736 |
SFXN4
|
Health Risk |
Pathogenic |
Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome, Growth and developmental delay-hypotonia-vision impairment-lactic acidosis syndrome |
| RS115628561 |
CPAP
|
Health Risk |
Conflicting classifications of pathogenicity |
Microcephaly 6, primary |
| RS1156299044 |
AMPD2
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia 63, Pontocerebellar hypoplasia type 9 |
| RS1156299203 |
HCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1156299579 |
TCIRG1
|
Health Risk |
Pathogenic |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS1156305904 |
GLE1
|
Health Risk |
Likely pathogenic |
GLE1-related disorder, GLE1-related disorder |
| RS1156323870 |
COL4A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Alport syndrome, Autosomal recessive Alport syndrome |
| RS1156325177 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome |
| RS1156330285 |
TRPS1
|
Health Risk |
Pathogenic |
Trichorhinophalangeal syndrome, type III |
| RS115633798 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Thymoma |
| RS1156344551 |
PIGS
|
Health Risk |
Likely pathogenic |
— |
| RS115635198 |
BBS12
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 12, BBS12-related disorder |
| RS1156352791 |
COL7A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Epidermolysis bullosa dystrophica, Recessive dystrophic epidermolysis bullosa |
| RS115638090 |
RUBCN
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1156390688 |
VPS13B
|
Health Risk |
Pathogenic/Likely pathogenic |
Cohen syndrome, Inborn genetic diseases |
| RS1156392394 |
MKS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Meckel-Gruber syndrome, Joubert syndrome |
| RS1156392436 |
TGM1
|
Health Risk |
Likely pathogenic |
Autosomal recessive congenital ichthyosis 1, Autosomal recessive congenital ichthyosis 1 |
| RS1156397632 |
FKBP10
|
Health Risk |
Pathogenic |
— |
| RS1156399205 |
CYFIP2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 65 |
| RS115640152 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1156407486 |
POLR1C
|
Health Risk |
Pathogenic |
Hypomyelinating leukodystrophy 11, Treacher Collins syndrome 3 |
| RS1156410886 |
TONSL
|
Health Risk |
Pathogenic |
— |
| RS1156410888 |
TNNT1
|
Health Risk |
Likely pathogenic |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS1156413585 |
RMRP
|
Health Risk |
Likely pathogenic |
Metaphyseal chondrodysplasia, McKusick type |
| RS1156416298 |
CAD
|
Health Risk |
Likely pathogenic |
— |
| RS11564176 |
LRRK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Parkinson disease 8, Autosomal dominant Parkinson disease 8 |
| RS1156424752 |
DPAGT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital myasthenic syndrome 13, Congenital myasthenic syndrome 13 |
| RS115643329 |
ERCC6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1156444972 |
FLNC
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 5, Hypertrophic cardiomyopathy 26 |
| RS1156445260 |
DEGS1
|
Health Risk |
Pathogenic |
— |
| RS1156454797 |
ZP2
|
Health Risk |
Pathogenic |
Oocyte maturation defect 6, Oocyte maturation defect 6 |
| RS1156454853 |
NDUFB9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS11564717 |
TH
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive DOPA responsive dystonia, Generalized dystonia |
| RS11564720 |
INS
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Maturity-onset diabetes of the young type 10 |
| RS1156473739 |
DNAH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia 7, Primary ciliary dyskinesia 7 |
| RS115647631 |
DNAH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ciliary dyskinesia, primary |
| RS1156500366 |
PMM2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1156500992 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS115650537 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Congenital muscular dystrophy due to partial LAMA2 deficiency |
| RS115651105 |
PGAP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1156517377 |
ETFDH
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple acyl-CoA dehydrogenase deficiency, Glutaric acidemia type 2C |
| RS1156524068 |
COL6A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Bethlem myopathy 1A |
| RS1156538773 |
LAMA2
|
Health Risk |
Pathogenic |
LAMA2-related muscular dystrophy, LAMA2-related muscular dystrophy |
| RS1156561540 |
ZMIZ1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1156563889 |
GUSB
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis type 7, Mucopolysaccharidosis type 7 |
| RS1156566314 |
SACS
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1156573190 |
FAM20A
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1G, Amelogenesis imperfecta type 1G |
| RS1156577591 |
FANCM
|
Health Risk |
Pathogenic/Likely pathogenic |
Fanconi anemia, Fanconi anemia |
| RS1156582406 |
AIRE
|
Health Risk |
Likely pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1156588840 |
MOCOS
|
Health Risk |
Conflicting classifications of pathogenicity |
Xanthinuria type II, Xanthinuria type II |
| RS115658952 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS115660279 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1156609341 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CHARGE syndrome |
| RS1156612738 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ovarian cancer |
| RS1156614886 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1156634884 |
CHRNE
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome, Congenital myasthenic syndrome 4A |
| RS115663668 |
TNNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 5, Nemaline myopathy 5 |
| RS1156647434 |
POMGNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2O, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1156662870 |
KCNT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 14 |
| RS1156693900 |
FANCF
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS115670342 |
TG
|
Health Risk |
Conflicting classifications of pathogenicity |
Iodotyrosyl coupling defect, TG-related disorder |
| RS115670442 |
PMS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1156737044 |
PATL2
|
Health Risk |
Likely pathogenic |
Oocyte maturation defect 4, Oocyte maturation defect 4 |
| RS1156745816 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1156747241 |
FBN1
|
Health Risk |
Pathogenic |
Marfan Syndrome/Loeys-Dietz Syndrome/Familial Thoracic Aortic Aneurysms and Dissections, Marfan syndrome |
| RS115675008 |
COL9A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Epiphyseal dysplasia, multiple |
| RS1156763944 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS115677373 |
TGM5
|
Health Risk |
Pathogenic/Likely pathogenic |
Acral peeling skin syndrome, Acral peeling skin syndrome |
| RS11567841 |
LCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to LCK deficiency, LCK-related disorder |
| RS11567847 |
TEAD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Helicoid peripapillary chorioretinal degeneration, Helicoid peripapillary chorioretinal degeneration |
| RS1156803164 |
IQCB1
|
Health Risk |
Pathogenic |
Senior-Loken syndrome 5, Senior-Loken syndrome 5 |
| RS1156805286 |
DYSF
|
Health Risk |
Pathogenic |
Miyoshi muscular dystrophy 1, Autosomal recessive limb-girdle muscular dystrophy type 2B |
| RS1156815415 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |
| RS11568178 |
MLC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Megalencephalic leukoencephalopathy with subcortical cysts 1, Megalencephalic leukoencephalopathy with subcortical cysts |
| RS1156823520 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms |
| RS1156833108 |
KARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Leukoencephalopathy, progressive |
| RS11568360 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS11568361 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS11568362 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS11568365 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
ABCB11-related disorder, Progressive familial intrahepatic cholestasis type 2 |
| RS11568372 |
ABCB11
|
Health Risk |
Pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis |
| RS11568423 |
SLC7A7
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysinuric protein intolerance, Autoinflammatory syndrome |